Clinical Practice Guidelines Online Education

The SITC Clinical Practice Guideline (CPG) Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the CPGs. Introductory webinars accompany each CPG and describe recommended uses of immunotherapies for a specific disease state and how to appropriately manage common and uncomplicated toxicities.

Advanced webinars for select CPGs:

Practical Management Pearls webinars cover optimal sequencing of immunotherapies in relapsed or refractory disease and integration of immunotherapies into treatment plans for early-stage cancers, as well as other advanced topics.
Case Studies webinars discuss immunotherapy treatment regimens for challenging patient populations, in addition to how to identify and manage uncommon and/or atypically responsive disease.

CPG Mini Modules (previously referred to as "Ten-Minute Modules"):

Available as enduring materials for the advanced live webinar series, three mini modules, 7-15 minutes in length, assist learners in applying lessons learned on specific topics within the use of immunotherapy in their own practices and locate additional resources to continue their education.

A free SITC Connect account is required for access to live webinars and enduring materials, including the mini modules (you will be prompted to create a SITC Connect account if you don’t already have one). If you have any difficulties, please reach out to connectED@sitcancer.org.

On-demand CPG Webinars

Acute Leukemia

*Immunotherapy for the Treatment of Acute Leukemia
View Video On-Demand

Practical Management Pearls for Immunotherapy for the Treatment of Acute Leukemia
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Acute Leukemia
View Video On-Demand

Breast Cancer

*Immunotherapy for the Treatment of Breast Cancer Guideline Overview
View Video On-Demand

*This webinar has no external funding sources.

Practical Management Pearls for Immunotherapy for the Treatment of Breast Cancer
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Breast Cancer
View Video On-Demand

Cutaneous Melanoma

*Immunotherapy for the Treatment of Cutaneous Melanoma
View Video On-Demand

*This webinar has no external funding sources.

Head and Neck Cancer

*Immunotherapy for the Treatment of Squamous Cell Carcinoma of the Head and Neck (HNSCC)
View Video On-Demand

Practical Management Pearls for Immunotherapy for the Treatment of Head and Neck Squamous Cell Carcinoma
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Head and Neck Squamous Cell Carcinoma
View Video On-Demand

Hepatocellular Carcinoma

*Immunotherapy for the Treatment of Hepatocellular Carcinoma Guideline Overview
View Video On-Demand

*This webinar has no external funding sources.

Practical Management Pearls for Immunotherapy for the Treatment of Hepatocellular Carcinoma
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Hepatocellular Carcinoma
View Video On-Demand

Immune Checkpoint Inhibitor-related Adverse Events

*Immune Checkpoint Inhibitor-related Adverse Events
View Video On-Demand

Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events
View Video On-Demand

Case Studies in Immune Checkpoint Inhibitor-related Adverse Events
View Video On-Demand

Immune Effector Cell-related Adverse Events

*Immune Effector Cell-related Adverse Events
View Video On-Demand

Practical Management Pearls for Immune Effector Cell-related Adverse Events
View Video On-Demand

Case Studies in Immune Effector Cell-related Adverse Events
View Video On-Demand

Lung Cancer and Mesothelioma

Practical Management Pearls for Immunotherapy for the Treatment of Lung Cancer and Mesothelioma
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Lung Cancer and Mesothelioma
View Video On-Demand

Lymphoma

*Immunotherapy for the Treatment of Lymphoma
View Video On-Demand

Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Lymphoma
View Video On-Demand

Multiple Myeloma

*Immunotherapy for the Treatment of Multiple Myeloma
View Video On-Demand

Practical Management Pearls for Immunotherapy for the Treatment of Multiple Myeloma
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Multiple Myeloma
View Video On-Demand

Nonmelanoma Skin Cancer

Practical Management Pearls for Immunotherapy for the Treatment of Nonmelanoma Skin Cancer
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Nonmelanoma Skin Cancer
View Video On-Demand

Non-Small Cell Lung Cancer (NSCLC)

*Immunotherapy for the Treatment of Non-small Cell Lung Cancer (NSCLC)
View Video On-Demand

*This webinar has no external funding sources.

Renal Cell Carcinoma

*Immunotherapy for the Treatment of Renal Cell Carcinoma
View Video On-Demand

Practical Management Pearls for Immunotherapy for the Treatment of Renal Cell Carcinoma
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Renal Cell Carcinoma
View Video On-Demand

Urothelial Cancer

*Immunotherapy for the Treatment of Urothelial Cancer Guideline Overview
View Video On-Demand

*This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP and Merck & Co., Inc.

Practical Management Pearls for Immunotherapy for the Treatment of Urothelial Cancer
View Video On-Demand

Case Studies in Immunotherapy for the Treatment of Urothelial Cancer
View Video On-Demand

*The indicated introductory webinars are jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer. CE credits are available to live webinar attendees. These webinars are also supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc. (unless noted otherwise).

The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 6/7/2022). CE credits are not available for these webinars.

The SITC Clinical Practice Guidelines are produced and funded solely by SITC. No outside funding is received for the development of the manuscripts.

Guidelines in Development

Gastrointestinal Cancer

Gynecological Cancer

Melanoma (Update)

CPG Mini Modules

Acute Leukemia

Breast Cancer

Head and Neck Squamous Cell Carcinoma

Hepatocellular Carcinoma

Immune Checkpoint Inhibitor-related Adverse Events

Immune Effector Cell-related Adverse Events

Lymphoma

Multiple Myeloma

Renal Cell Carcinoma

Urothelial Cancer

Clinical Practice Guidelines Online Education

On-demand CPG Webinars

Acute Leukemia

Breast Cancer

Cutaneous Melanoma

Head and Neck Cancer

Hepatocellular Carcinoma

Immune Checkpoint Inhibitor-related Adverse Events

Immune Effector Cell-related Adverse Events

Lung Cancer and Mesothelioma

Lymphoma

Multiple Myeloma

Nonmelanoma Skin Cancer

Non-Small Cell Lung Cancer (NSCLC)

Renal Cell Carcinoma

Urothelial Cancer

Guidelines in Development

CPG Mini Modules

Membership Links

Get Involved